MedTrace Logo

Controlling Myopia Progression With Soft Contact Lenses

NCT00762970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.

Conditions

  • Myopia

Interventions

DEVICE

Test Lens 1

Investigational soft contact lens with asperic optical design to control myopia progression.

DEVICE

Test Lens 2

Investigational soft contact lens with asperic optical design to control myopia progression.

DEVICE

Control Lens

Spectacle Lenses.

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Xu Cheng, MD, PhD · Principal Clinical Scientist

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-01
Primary Completion
2010-02-01
Completion
2010-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762970 on ClinicalTrials.gov